| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Relay Therapeutics Inc (NASDAQ: RLAY)
RLAY Technical Analysis
5
| As on 9th Jun 2023 RLAY STOCK Price closed @ 10.75 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 22.64 & Strong Sell for SHORT-TERM with Stoploss of 24.74 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RLAYSTOCK Price
| Open | 11.16 | Change | Price | % |
| High | 11.16 | 1 Day | -0.41 | -3.67 |
| Low | 10.63 | 1 Week | -0.25 | -2.27 |
| Close | 10.75 | 1 Month | -1.03 | -8.74 |
| Volume | 860925 | 1 Year | -18.46 | -63.20 |
| 52 Week High 34.88 | 52 Week Low 9.99 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| RLAY Daily Charts |
RLAY Intraday Charts |
Whats New @ Bazaartrend |
RLAY Free Analysis |
|
|
RLAY Important Levels Intraday
| RESISTANCE | 11.77 |
| RESISTANCE | 11.44 |
| RESISTANCE | 11.24 |
| RESISTANCE | 11.04 |
| SUPPORT | 10.46 |
| SUPPORT | 10.26 |
| SUPPORT | 10.06 |
| SUPPORT | 9.73 |
RLAY Forecast May 2024
| 4th UP Forecast | 35.07 |
| 3rd UP Forecast | 27.27 |
| 2nd UP Forecast | 22.45 |
| 1st UP Forecast | 17.63 |
| 1st DOWN Forecast | 3.87 |
| 2nd DOWN Forecast | -0.95 |
| 3rd DOWN Forecast | -5.77 |
| 4th DOWN Forecast | -13.57 |
RLAY Weekly Forecast
| 4th UP Forecast | 18.21 |
| 3rd UP Forecast | 15.82 |
| 2nd UP Forecast | 14.34 |
| 1st UP Forecast | 12.86 |
| 1st DOWN Forecast | 8.64 |
| 2nd DOWN Forecast | 7.16 |
| 3rd DOWN Forecast | 5.68 |
| 4th DOWN Forecast | 3.29 |
RLAY Forecast2024
| 4th UP Forecast | 60.25 |
| 3rd UP Forecast | 44.38 |
| 2nd UP Forecast | 34.56 |
| 1st UP Forecast | 24.75 |
| 1st DOWN Forecast | -3.25 |
| 2nd DOWN Forecast | -13.06 |
| 3rd DOWN Forecast | -22.88 |
| 4th DOWN Forecast | -38.75 |
Relay Therapeutics Inc ( NASDAQ USA Symbol : RLAY )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RLAY Business Profile
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The company's lead product candidates include RLY-1971, an oral small molecule inhibitor of protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-2 that is in Phase 1 trial in patients with advanced solid tumors; RLY-4008, an oral small molecule selective inhibitor of fibroblast growth factor receptor 2 (FGFR2), which is in a first-in-human clinical trial for patients with advanced solid tumors having oncogenic FGFR2 alterations; and RLY-PI3K1047, a lead compound that targets cancer-associated mutant variants of phosphoinositide 3-kinase alpha. It has collaboration and license agreements with D. E. Shaw Research, LLC to research certain biological targets through the use of D. E. Shaw Research computational modeling capabilities focused on analysis of protein motion to develop and commercialize compounds and products directed to such targets; and Genentech, Inc. for the development and commercialization of RLY-1971. The company was formerly known as Allostery, Inc. and changed its name to Relay Therapeutics, Inc. in December 2015. Relay Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Address: 399 Binney Street, Cambridge, MA, United States, 02139
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service